These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 38553255)

  • 1. Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
    Hjermstad MJ; Jakobsen G; Arends J; Balstad TR; Brown LR; Bye A; Coats AJS; Dajani OF; Dolan RD; Fallon MT; Greil C; Grzyb A; Kaasa S; Koteng LH; May AM; McDonald J; Ottestad I; Philips I; Roeland EJ; Sayers J; Simpson MR; Skipworth RJE; Solheim TS; Sousa MS; Vagnildhaug OM; Laird BJA;
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):794-815. PubMed ID: 38553255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
    Vagnildhaug OM; Balstad TR; Ottestad I; Bye A; Greil C; Arends J; Baracos V; Brown LR; Dajani OF; Dolan RD; Fallon M; Fraser E; Grzyb A; Hjermstad MJ; Jakobsen G; Kaasa S; McDonald J; Philips I; Sayers J; Simpson MR; Sousa MS; Skipworth RJE; Laird BJA; Solheim TS;
    J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):513-535. PubMed ID: 38343065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
    McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.
    Brown LR; Sousa MS; Yule MS; Baracos VE; McMillan DC; Arends J; Balstad TR; Bye A; Dajani O; Dolan RD; Fallon MT; Greil C; Hjermstad MJ; Jakobsen G; Maddocks M; McDonald J; Ottestad IO; Phillips I; Sayers J; Simpson MR; Vagnildhaug OM; Solheim TS; Laird BJA; Skipworth RJE;
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):816-852. PubMed ID: 38738581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series.
    Yule MS; Thompson J; Leesahatsawat K; Sousa MS; Anker SD; Arends J; Balstad TR; Brown LR; Bye A; Dajani O; Fallon M; Hjermstad MJ; Jakobsen G; McDonald J; McGovern J; Roeland EJ; Sayers J; Skipworth RJE; Ottestad IO; Philips I; Simpson MR; Solheim TS; Vagnildhaug OM; McMillan D; Laird BJA; Dolan RD;
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):853-867. PubMed ID: 38783477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise for cancer cachexia in adults.
    Grande AJ; Silva V; Sawaris Neto L; Teixeira Basmage JP; Peccin MS; Maddocks M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010804. PubMed ID: 33735441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review.
    Johns JR; Vyas J; Ali FM; Ingram JR; Salek S; Finlay AY
    Br J Dermatol; 2024 Sep; 191(4):497-507. PubMed ID: 38819233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
    Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
    Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. There are Considerable Inconsistencies Among Minimum Clinically Important Differences in TKA: A Systematic Review.
    Deckey DG; Verhey JT; Gerhart CRB; Christopher ZK; Spangehl MJ; Clarke HD; Bingham JS
    Clin Orthop Relat Res; 2023 Jan; 481(1):63-80. PubMed ID: 36200846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures.
    Kwon J; Freijser L; Huynh E; Howell M; Chen G; Khan K; Daher S; Roberts N; Harrison C; Smith S; Devlin N; Howard K; Lancsar E; Bailey C; Craig J; Dalziel K; Hayes A; Mulhern B; Wong G; Ratcliffe J; Petrou S
    Pharmacoeconomics; 2022 Apr; 40(4):379-431. PubMed ID: 35072935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).
    King MT; Agar M; Currow DC; Hardy J; Fazekas B; McCaffrey N
    Support Care Cancer; 2020 Jan; 28(1):141-153. PubMed ID: 30993452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.